Use of antibiotics in a haematology ward - An audit

Annals of the Academy of Medicine Singapore

Volumn 37, Issue 1, 2008, Pages 21-26

  Gee, Chuan Wong ^a   Ban, Hock Tan ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Adherence; Chemotherapy; Febrile neutropenia; Leukaemia; Resistance

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; MITOXANTRONE; TAZOBACTAM; VANCOMYCIN; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; HEALTH SURVEY; HUMAN; MONOTHERAPY; MYCOSIS; PRACTICE GUIDELINE;

EID: 41149112992     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Ascioglu S, Rex RH, de Pauw Ben, Bennett JE, Bille J, Croakert F, et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
2. Tan BH, Leo YS, Chew SK. Lessons from the SARS crisis - more relevant than ever. Ann Acad Med Singapore 2006;35:299-300.
3. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51.
4. Anonymous. Evidence-based recommendations on antimicrobial use in febrile neutropenia in Japan. Int J Hematol 1998;68 (Suppl 1): S5-S6.
5. Donowitz GR, Maki DG, Crnich CJ, Pappas PG, Rolston KV. Infections in the neutropenic patient - new views of an old problem. Hematology Am Soc Hematol Educ Program 2001;113-39.
6. Viscoli C, Castagnola E. Planned progressive antimicrobial therapy in neutropenic patients. Br J Haematol 1998;102;102:879-88.
7. Livermore DM, Oakton KJ, Carter MW, Warner M. Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent β-lactamases. Antimicrob Agents Chemother 2001;45:2831-7.
8. Yamamura D, Gucalp R, Carlisle P, Cimino M, Roberts J, Rotstein C. Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients. Antimicrob Agents Chemother 1997;41:1704-8.
9. Sanz MA, Lopez J, Lahuerta JJ, Rovira M, Batlle M, Perez C, et al. Spanish PETHEMA Group. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial. J Antimicrob Chemother 2002;50:79-88.
10. Ziglam HM, Gelly KJ, Olver WJ. A survey of the antibiotic treatment of febrile neutropenia in haematology units in the United Kingdom. Clin Lab Hematol 2005;27:374-8.
11. Chamberlain JD, Smibert E, Skeen J, Alvaro F. Prospective audit of treatment of paediatric febrile neutropenia in Australasia. J Paediatr Child Health 2005;41:598-603.
12. Engervall P, Gunther P, Ljungman P, Lonnqvist B, Hast R, Stiernstedt G,et al.Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients. J Chemother 1996;8:382-6.
13. Jandula BM, Martino R, Gurgi M, Manteiga R, Sierra J. Treatment of febrile neutropenia with cefepime monotherapy. Chemotherapy 2001; 47:226-31.
14. Cordonnier C, Herbrecht R, Pico JL, Gardembas M, Delmer A, Delain M, et al. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group. Clin Infect Dis 1997;24:41-51.
15. Innes H, Billingham L, Gaunt C, Steven N, Marshall E. Management of febrile neutropenia in the United Kingdom: time for a national trial? Br J Cancer 2005;93:1324-8.